Proteolysis-concentrating on chimeras (PROTACs) and molecular glue degraders (MGDs) are one of the most maturely created TPD procedures. During this overview, we focus on both of those preclinical experiments and scientific trials to supply a comprehensive summary of the protection and medical success of PROTACs and MGDs in hematologic malignancies https://mahatmak308afi1.is-blog.com/profile